Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells

被引:34
|
作者
Kallio, Anu [2 ,3 ]
Guo, Tao [2 ,4 ,5 ]
Lamminen, Elisa [2 ]
Seppanen, Jani [2 ]
Kangas, Lauri [6 ]
Vaananen, H. Kalervo [2 ]
Harkonen, Pirkko [1 ]
机构
[1] Lund Univ, MAS Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden
[2] Univ Turku, Inst Biomed, Dept Anat, FIN-20520 Turku, Finland
[3] Turku Grad Sch Biomed Sci, Turku, Finland
[4] Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Wuhan 430022, Hubei, Peoples R China
[5] Lab Biotargeted Therapy Hubei Prov, Wuhan 430022, Hubei, Peoples R China
[6] Hormos Med Ltd, Turku, Finland
基金
芬兰科学院;
关键词
osteoblast; U2OS; estradiol; estrogen receptor; OPG; IL-6;
D O I
10.1016/j.mce.2008.03.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In the current work, we compared the ability of 17 beta-estradiol (E-2) and the selective estrogen receptor modulators (SERMs), tamoxifen (Tam), raloxifene (Ral) and ospemifene (Osp) to promote the survival of osteoblast-derived cells against etoposide-incluced apoptosis. In order to compare the roles of the two estrogen receptor (ER) isotypes, we created a U2OS human osteosarcoma cell line stably expressing either ERalpha (ER alpha) or ERbeta (ER beta). Transfection with either of the ERs was able to render the U2OS cells sensitive to E-2. We show that E2 opposed etoposide-induced apoptosis and that the effect was mediated via both ER isotypes. The ER isotype selective agonists propyl-pyrazole-triol (PPT) and diarylpropionitrile (DPN) had the same effect in U2OS/ER alpha and U20S/ER beta cells, respectively. Osp also opposed apoptosis at least in U2OS/ERa cells. Tam and Ral were not able to protect against etoposide-induced cell death. In order to evaluate the protective effects of E-2 and Osp upon etoposide challenge, we studied the expression of two E-2-regulated, osteoblast-produced cytokines, IL-6 and OPG in E-2 and SERM-treated U2OS/ER alpha and U2OS/ER beta cells. Etoposide strongly increased expression of IL-6 and decreased that of OPG. E-2 opposed IL-6 increase only in U2OS/ER alpha cells and OPG decrease primarily in ER beta cells. Osp opposed the effect of etoposide on OPG primarily in U2OS/ER beta cells but interestingly, it had little effect on IL-6 expression. E2, PPT, DNP and Osp also inhibited etoposide-induced death and cytokine changes in SAOS-2 osteosarcoma cells expressing endogenous ER alpha and ER beta. Collectively, our results suggest that the osteoblast protective anti-apoptotic effects of E-2 are mediated by both ER alpha and ER beta but those of Osp primarily by ER alpha. In addition, E-2 and Osp opposed the etoposide-induced increase of IL-6 and decrease of OPG which changes would increase osteoclastic activity. These anti-resorptive effects of E-2 and Osp upon etoposide challenge differed from each other and they seemed to be differentially mediated in ER(x and ER beta expressing osteoblast-derived U2OS cells. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:38 / 48
页数:11
相关论文
共 50 条
  • [42] Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell
    Wang, Jir-You
    Chen, Chao-Ming
    Chen, Cheng-Fong
    Wu, Po-Kuei
    Chen, Wei-Ming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (20)
  • [43] Comparison of ERA-923, a new selective estrogen receptor modulator (SERM) for the treatment of estrogen-receptor positive breast cancer, with other SERMs.
    Greenberger, LM
    Komm, B
    Miller, C
    Annable, T
    Lyttle, R
    Frost, P
    CLINICAL CANCER RESEARCH, 2000, 6 : 4565S - 4565S
  • [44] Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension
    Abdulkareem, Adam Olaitan
    Tiwari, Priya
    Lone, Zahid Rasool
    Iqbal, Hina
    Gupta, Satish
    Jha, Rajesh Kumar
    Chanda, Debabrata
    Jagavelu, Kumaravelu
    Hanif, Kashif
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 943
  • [45] Estrogen causes cell death of estrogen receptor stably transfected cells via apoptosis
    Lee, Y
    Renaud, RA
    Friedrich, TC
    Gorski, J
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 67 (04): : 327 - 332
  • [46] Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma
    Chantzi, Miki I.
    Tiniakos, Dina G.
    Palaiologou, Marina
    Goutas, Nikolaos
    Filippidis, Theodoros
    Vassilaros, Stamatis D.
    Dhimolea, Eugen
    Mitsiou, Dimitra J.
    Alexis, Lichael N.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (09) : 1489 - 1498
  • [47] Effects of a novel selective estrogen receptor modulator (SERM) on cell proliferation and growth in a macaque autograft model for endometriosis.
    Carroll, R.
    Kaufmann-Reiche, U.
    Schmidt, A.
    Fuhrmann, U.
    Fritzemejer, K. H.
    Slayden, O. D.
    FERTILITY AND STERILITY, 2007, 88 : S60 - S60
  • [48] Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma
    Νiki Ι. Chantzi
    Dina G. Tiniakos
    Marina Palaiologou
    Nikolaos Goutas
    Theodoros Filippidis
    Stamatis D. Vassilaros
    Eugen Dhimolea
    Dimitra J. Mitsiou
    Μichael N. Alexis
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1489 - 1498
  • [49] Selective estrogen receptor modulator regulated proteins in endometrial cancer cells
    Shah, YM
    Basrur, V
    Rowan, BG
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 219 (1-2) : 127 - 139
  • [50] Conversion of the phytoestrogen coumestrol into a selective estrogen receptor modulator (SERM) by attachment of an amine-containing sidechain
    Grese, TA
    Cole, HW
    Magee, DE
    Phillips, DL
    Shetler, PK
    Short, LL
    Glasebrook, AL
    Bryant, HU
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (22) : 2683 - 2686